glp-1 prescriptions Medications: Everything You Need to Know Just how many Americans are

Funding This work was supported by the Italian Ministry of Health (RRC)

Petersen JA, Wilm BJ, von Meyenburg J, Schubert M, Seifert B, Najafi Y, et al

V: NIH Toolbox Cognition Battery (CB): measuring working memory

Cependant, les tudes incluses dans ces analyses taient de faible qualit

According to health industry pollster KFF, in 2025 1 in 8 people 12% said they were currently taking a GLP-1 drug, and 18% said they have taken the weight-loss drug at some point

While Zepbound is not directly known to cause NAION, its effects on blood sugar and potential impacts on vascular health in diabetic patients could theoretically contribute to an increased risk